Description

7-(1,3-Benzodioxol-5-Yl)-2-(tert-Butyl)[1,2,4]Triazolo[1,5-A]Pyridine-8-Carbonitrile is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is critical for the synthesis of novel active pharmaceutical ingredients (APIs) targeting specific therapeutic pathways. It is primarily required by R&D laboratories and manufacturers in the pharmaceutical and agrochemical industries for developing next-generation treatments and products.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates, particularly in central nervous system (CNS) and oncology research.
• Agrochemical Research: Used in the development of new pesticides and herbicides due to its unique bioactive scaffold.
• Chemical Biology Probe: Serves as a precursor for creating specialized molecular probes to study enzyme inhibition and receptor binding.
• Material Science Research: Investigated as a potential component for organic electronic materials and photoactive compounds.
• Contract Research Organizations (CROs): Supplied to CROs for client-sponsored drug discovery and development programs.
• Academic Research: Utilized in university and institutional labs for medicinal chemistry and heterocyclic compound studies.

Basic Information

Product Name	7-(1,3-Benzodioxol-5-Yl)-2-(tert-Butyl)[1,2,4]Triazolo[1,5-A]Pyridine-8-Carbonitrile
CAS No.	860650-24-4
Molecular Formula	C19H18N4O2
Molecular Weight	334.37 g/mol
Synonyms	2-tert-Butyl-7-(1,3-benzodioxol-5-yl)[1,2,4]triazolo[1,5-a]pyridine-8-carbonitrile; 860650-24-4; 7-(Benzo[d][1,3]dioxol-5-yl)-2-(tert-butyl)[1,2,4]triazolo[1,5-a]pyridine-8-carbonitrile; 2-(tert-Butyl)-7-(1,3-benzodioxol-5-yl)-[1,2,4]triazolo[1,5-a]pyridine-8-carbonitrile; [1,2,4]Triazolo[1,5-a]pyridine-8-carbonitrile, 7-(1,3-benzodioxol-5-yl)-2-(1,1-dimethylethyl)-; 7-(1,3-Benzodioxol-5-yl)-2-(tert-butyl)[1,2,4]triazolo[1,5-a]pyridine-8-carbonitrile
EINECS	Contact for details

Quality Control

Our production of 7-(1,3-Benzodioxol-5-Yl)-2-(tert-Butyl)[1,2,4]Triazolo[1,5-A]Pyridine-8-Carbonitrile adheres to stringent quality management systems, ensuring batch-to-batch consistency for critical R&D and scale-up processes. Each lot is characterized and released with a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We support compliance with cGMP and ISO 9001 standards for pharmaceutical intermediates, and specifications can be aligned with client-specific pharmacopeial requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). This material is light-sensitive (store away from light). Keep the container tightly sealed in a dry environment to minimize moisture uptake.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Any single impurity ≤ 0.5%; Total impurities ≤ 2.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.